Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification

Abstract

Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.

Connecting the Dots: Understanding Biopsychosocial Factors Influencing Opioid Use Treatment Outcomes for Rural Adults

“…The finding that rurality predicts shorter TD lends statistical credence to what is already well-established on the ground in practice: the more rurally located the clients the harder it is to sustain treatment, often related to transportation and travel distance barriers (Lister et al, 2020). Rurality may contribute to a decreased likelihood of reducing use by the end of the treatment period, as predicted in the analysis, since TD has been associated with reduced use (Amato et al, 2011;Mattick et al, 2009;NIDA, 2018).…”

Connecting the Dots: Understanding Biopsychosocial Factors Influencing Opioid Use Treatment Outcomes for Rural Adults

“…The finding that rurality predicts shorter TD lends statistical credence to what is already well-established on the ground in practice: the more rurally located the clients the harder it is to sustain treatment, often related to transportation and travel distance barriers (Lister et al, 2020). Rurality may contribute to a decreased likelihood of reducing use by the end of the treatment period, as predicted in the analysis, since TD has been associated with reduced use (Amato et al, 2011;Mattick et al, 2009;NIDA, 2018).…”

A Randomized, Double-blind Evaluation of Buprenorphine Taper Duration in Primary Prescription Opioid Abusers

“…However, although these data suggest that a meaningful subset of PO-dependent patients may do well with a carefully implemented buprenorphine detoxification regimen, ongoing antagonist therapy and other services will likely be important for longer-term success. 36 To the extent that naltrexone helped prevent relapse in the present study, recently developed sustained-release naltrexone formulations could provide ongoing pharmacologic support following detoxification. 66 …”

Exploring mortality among drug treatment clients: The relationship between treatment type and mortality

“…If abstinence is desired by a client undergoing OST, typically psycho-social based treatments are employed while OST is tapered and eventually eliminated. These psycho-social treatments include behavioral treatments such as counselling and family therapy (Amato et al, 2011& Vecchi, 2011. Thus, the elevated risk period immediately following treatment cessation that has been identified in previous research may indeed point to elevated risk during post-OST abstinence-based treatments.…”

Connecting the Dots: Understanding Biopsychosocial Factors Influencing Opioid Use Treatment Outcomes for Rural Adults

“…The finding that rurality predicts shorter TD lends statistical credence to what is already well-established on the ground in practice: the more rurally located the clients the harder it is to sustain treatment, often related to transportation and travel distance barriers (Lister et al, 2020). Rurality may contribute to a decreased likelihood of reducing use by the end of the treatment period, as predicted in the analysis, since TD has been associated with reduced use (Amato et al, 2011;Mattick et al, 2009;NIDA, 2018).…”

A Randomized, Double-blind Evaluation of Buprenorphine Taper Duration in Primary Prescription Opioid Abusers

“…However, although these data suggest that a meaningful subset of PO-dependent patients may do well with a carefully implemented buprenorphine detoxification regimen, ongoing antagonist therapy and other services will likely be important for longer-term success. 36 To the extent that naltrexone helped prevent relapse in the present study, recently developed sustained-release naltrexone formulations could provide ongoing pharmacologic support following detoxification. 66 …”

Exploring mortality among drug treatment clients: The relationship between treatment type and mortality

“…If abstinence is desired by a client undergoing OST, typically psycho-social based treatments are employed while OST is tapered and eventually eliminated. These psycho-social treatments include behavioral treatments such as counselling and family therapy (Amato et al, 2011& Vecchi, 2011. Thus, the elevated risk period immediately following treatment cessation that has been identified in previous research may indeed point to elevated risk during post-OST abstinence-based treatments.…”

Connecting the Dots: Understanding Biopsychosocial Factors Influencing Opioid Use Treatment Outcomes for Rural Adults

“…The finding that rurality predicts shorter TD lends statistical credence to what is already well-established on the ground in practice: the more rurally located the clients the harder it is to sustain treatment, often related to transportation and travel distance barriers (Lister et al, 2020). Rurality may contribute to a decreased likelihood of reducing use by the end of the treatment period, as predicted in the analysis, since TD has been associated with reduced use (Amato et al, 2011;Mattick et al, 2009;NIDA, 2018).…”

A Randomized, Double-blind Evaluation of Buprenorphine Taper Duration in Primary Prescription Opioid Abusers

“…However, although these data suggest that a meaningful subset of PO-dependent patients may do well with a carefully implemented buprenorphine detoxification regimen, ongoing antagonist therapy and other services will likely be important for longer-term success. 36 To the extent that naltrexone helped prevent relapse in the present study, recently developed sustained-release naltrexone formulations could provide ongoing pharmacologic support following detoxification. 66 …”

Exploring mortality among drug treatment clients: The relationship between treatment type and mortality

“…If abstinence is desired by a client undergoing OST, typically psycho-social based treatments are employed while OST is tapered and eventually eliminated. These psycho-social treatments include behavioral treatments such as counselling and family therapy (Amato et al, 2011& Vecchi, 2011. Thus, the elevated risk period immediately following treatment cessation that has been identified in previous research may indeed point to elevated risk during post-OST abstinence-based treatments.…”